Latest Period
n/a
Security Snapshot
Oncology Institute, Inc. - Common (DFPH) Institutional Ownership
CUSIP: 23343Q100
13F Institutional Holders and Ownership History from Q2 2020 to Q1 2023
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common
- Symbol
- DFPH
- Shares outstanding
- 98,364,308
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- DFPH - Oncology Institute, Inc. - Common is tracked under CUSIP 23343Q100.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 0 between Q4 2022 and Q1 2023.
- Reported value moved from $15 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
23343Q100
Latest holder period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
DFPH full holder history
Oncology Institute, Inc. SEC filings
Oncology Institute, Inc. company facts
Oncology Institute, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 23343Q100:
Significant Owners of Oncology Institute, Inc. - Common (DFPH) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| M33 Growth I L.P. | 5.5% | -43% | 6,802,656 | -27% | M33 Growth I LP | 18 Nov 2025 | ||
| Chernett Jorey | 5.2% | 5,114,944 | Chernett Jorey | 14 Jan 2026 |
Institutional Holders of Oncology Institute, Inc. - Common (DFPH) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q1 | 0 | $0 | -$15 | 0 | |
| 2022 Q4 | 9 | $15 | +$15 | $1.67 | 1 |
| 2021 Q4 | 0 | $0 | -$204,861,000 | 0 | |
| 2021 Q3 | 21,816,421 | $216,702,000 | +$2,122,146 | $9.94 | 50 |
| 2021 Q2 | 21,595,639 | $214,731,000 | -$45,568,035 | $9.95 | 53 |
| 2021 Q1 | 26,163,998 | $260,591,000 | +$70,992,437 | $9.96 | 49 |
| 2020 Q4 | 18,985,351 | $205,036,000 | +$99,023,502 | $10.80 | 48 |
| 2020 Q3 | 9,372,698 | $97,174,000 | +$44,916,624 | $10.36 | 37 |
| 2020 Q2 | 5,053,799 | $50,841,000 | +$50,841,000 | $10.05 | 21 |